- Report
- January 2025
- 100 Pages
Global
From €5247EUR$5,950USD£4,526GBP
- Report
- May 2025
- 188 Pages
Global
From €3126EUR$3,545USD£2,697GBP
€3474EUR$3,939USD£2,996GBP
- Report
- April 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- July 2025
- 93 Pages
Global
From €4939EUR$5,600USD£4,260GBP
- Report
- July 2025
- 382 Pages
Global
From €5159EUR$5,850USD£4,450GBP
- Report
- March 2025
- 180 Pages
Global
From €3373EUR$3,825USD£2,910GBP
€3969EUR$4,500USD£3,423GBP
- Drug Pipelines
- April 2025
- 280 Pages
Global
From €2646EUR$3,000USD£2,282GBP
- Report
- December 2024
- 159 Pages
Global
From €3484EUR$3,950USD£3,005GBP
- Report
- June 2025
- 150 Pages
Global
From €2380EUR$2,699USD£2,053GBP
- Report
- November 2024
- 39 Pages
Global
From €3523EUR$3,995USD£3,039GBP
- Report
- May 2025
- 193 Pages
Global
From €3126EUR$3,545USD£2,697GBP
€3474EUR$3,939USD£2,996GBP
From €4321EUR$4,900USD£3,727GBP
- Report
- October 2024
- 200 Pages
Global
From €3307EUR$3,750USD£2,853GBP
- Report
- June 2025
- 400 Pages
Global
From €4365EUR$4,949USD£3,765GBP
- Report
- January 2025
- 250 Pages
Global
From €4409EUR$4,999USD£3,803GBP
- Report
- October 2024
- 318 Pages
Global
From €7011EUR$7,950USD£6,048GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1764EUR$2,000USD£1,521GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2460EUR$2,789USD£2,122GBP
- Report
- June 2025
- 209 Pages
Global
From €2205EUR$2,500USD£1,902GBP
- Report
- May 2025
- 130 Pages
Global
From €4277EUR$4,850USD£3,689GBP

The Parkinson Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Parkinson's Disease is a progressive neurological disorder that affects movement, and is caused by a lack of dopamine in the brain. Parkinson Drugs are used to treat the symptoms of the disease, and can include levodopa, dopamine agonists, monoamine oxidase inhibitors, and catechol-O-methyltransferase inhibitors. These drugs can help to improve motor function, reduce tremors, and improve quality of life.
The Parkinson Drug market is highly competitive, with many companies offering a range of treatments. Some of the major players in the market include AbbVie, GlaxoSmithKline, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more